Amylyx gains nearly $600M in market cap after FDA committee gives green light

Amylyx Pharmaceuticals Inc. shares were riding high in the first few hours of trading following a key FDA advisory committee’s positive vote on its first drug, despite the unusual caveats that accompanied the vote.